Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Robert Redfield says he's "proud" of work on President Trump's initiative but believes COVID vaccines should be "critically ...

Keeping people healthy through innovative medicines and vaccines is a cornerstone to Pfizer’s mission to create breakthroughs ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

Health officials have advised people to get the updated COVID-19 vaccine ahead of the holidays — at least two weeks before.

"I don’t want to have a heart attack" by taking any more jabs, relatively young agency branch chief tells undercover date.

NEW YORK, October 29, 2024--Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2024 and raised its full ... (FDA) has approved ABRYSVO® (Respiratory Syncytial Virus Vacci ...

Moderna has secured FDA approval for its respiratory ... effect seen with both GSK and Pfizer’s products. There’s still one more step before Moderna’s vaccine can take on Arexvy and Abrysvo ...

To potentially include adolescents and antibody persistence up to two years ...

a full week ahead of its Nov. 29 PDUFA date. The approval of Attruby—as the drug will henceforth be known—sets up a potential three-way race in the transthyretin amyloid cardiomyopathy (ATTR-CM) ...

in the same ballpark as approved vaccines, with a safety profile similar to Comirnaty in a phase 1/2 trial that prompted them to start a phase 3 programme. In a joint statement, Pfizer and ...